cerrar
Tagged with Pricing

Algeria pharma comes of age
Newcomers to Algeria’s fledgling, but increasingly vibrant pharmaceuticals sector are immediately struck by the sense of liveliness pervading the…

How Healthcare Works in the UAE
How quickly can a country truly transform its healthcare system, while making it sustainable for the future? The mindset of Emiratis is that anything…

Poland’s Reimbursement Act: a cut too far?
“Cost containment measures are not just a Polish story, but a European reality,” says Marcin Hanczaruk, general manager at Amgen. “The…

PEMANDU – Chua Hong Teck, Director of the Healthcare…
PEMANDU’s Director for the Healthcare National Key Economic Area gives a thorough understanding of the various entry point projects that were…

Interview: José Aranda da Silva, General Manager, Formifarma,…
José Aranda da Silva, General Manager of Formifarma Portugal, stresses the importance of market access, demonstrating added value for companies…

Interview: David Setboun, Country President, AstraZeneca Portugal
David Setboun, Country President of AstraZeneca, discusses the opportunities that the Portuguese market can bring despite economic downturn, and the…

Interview: Christian L Macher, General Manager, AstraZeneca…
My advice for this market is to launch and see. The only way you can survive in here is if you have a lot of innovations, because then you don’t…

Interview: Lars Johansson, Managing Director Nordics, Janssen
Sweden and the Nordics are indeed an area for innovation. There is a tradition of innovation here: Skype and Spotify were founded here and the region…

Interview: Tom Rönnlund, General Manager Nordic & Baltic…
Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of austerity, and offers opinions on reference…

Interview with Fergal Murphy, Chairman, Association of…
Fergal Murphy, Chairman of the Association of Pharmaceutical Manufacturers in Ireland, discusses with pharamaboardroom.com the difficulties in such a…

Interview with Carlos Espíndola-Scapetta, Senior Partner,…
An expert in trade and regulatory issues relating to the pharmaceutical industry in Colombia, the senior partner of Espíndola International…

Interview: Peter Erlbacher, Chief Operations Officer, Spanish…
The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here